Q2 2018 Holdings
Filed 2018-08-14 | 17 holdings | $51.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $19.4M | 2,651,825 | 37.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $18.0M | 270,424 | 34.7% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $10.6M | 529,551 | 20.4% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $3.6M | 295,000 | 7.0% |
| Insmed Incorporated(INSM) | COM | 457669307 | $42.6K | 1,800,587 | 0.1% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $33.6K | 851,200 | 0.1% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $29.2K | 1,231,543 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $28.1K | 565,755 | 0.1% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $27.2K | 2,023,369 | 0.1% |
| OptiNose, Inc. | COM | 68404V100 | $26.0K | 928,545 | 0.1% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $22.6K | 721,903 | 0.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $17.9K | 1,130,919 | 0.0% |
| Alder BioPharmaceuticals, Inc.Put | COM | 014339955 | $5.5K | 350,000 | 0.0% |
| Eidos Therapeutics, Inc.(EIDXGBP) | COM | 28249H104 | $5.0K | 245,082 | 0.0% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $2.2K | 75,000 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | $1.6K | 94,477 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $403 | 10,650 | 0.0% |